Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04612036 · ClinicalTrials.gov registry record
In Vivo Kinematics for Subjects With Smith & Nephew Journey II BCS TKA, Journey II CR TKA, Or Journey II XR TKA
A clinical trial, sponsored by The University of Tennessee, Knoxville.
- Completed
- Registry status
- 60
- Enrollment target
NCT04612036: Completed study, sponsored by The University of Tennessee, Knoxville.
NCT04612036 is a clinical trial that has completed, run by The University of Tennessee, Knoxville. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04612036 has completed, sponsored by The University of Tennessee, Knoxville.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The objective of this study is to determine and compare the in vivo kinematics and vibroarthrography (VAG) signals for subjects implanted with Journey II Bi-Cruciate Stabilized (BCS), CR (Cruciate Retaining), and Bi-Cruciate Retaining (XR) TKAs.
Primary Outcome
Anterior Posterior (AP) translations, in mm, of medial femoral condyle during Deep Knee Bend Activity. Values are based on the participants range of motion throughout their DKB activity. A positive number indicated anterior sliding from full extension to maximum flexion, and a negative number indicated posterior rollback from full extension to maximum flexion.
Interventions
- DEVICE Journey II Bi-Cruciate Stabilized TKA
- DEVICE Journey II Cruciate Retaining TKA
- DEVICE Journey II Bi-Cruciate Retaining TKA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2020-10-22 |
| Est. Completion | 2022-05-16 |
What the finished NCT04612036 record still lists
NCT04612036 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Journey II Bi-Cruciate Stabilized TKA is the first listed.
NCT04612036 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04612036 about?
NCT04612036 is a clinical study titled "In Vivo Kinematics for Subjects With Smith & Nephew Journey II BCS TKA, Journey II CR TKA, Or Journey II XR TKA". The objective of this study is to determine and compare the in vivo kinematics and vibroarthrography (VAG) signals for subjects implanted with Journey II Bi-Cruciate Stabilized (BCS), CR (Cruciate Retaining), and Bi-Cruciate Retaining (XR) TKAs.
What is the current status of trial NCT04612036?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2020-10-22. Estimated completion is 2022-05-16.
What interventions are being tested in trial NCT04612036?
The interventions under investigation include: Journey II Bi-Cruciate Stabilized TKA (DEVICE), Journey II Cruciate Retaining TKA (DEVICE), Journey II Bi-Cruciate Retaining TKA (DEVICE).
Who is sponsoring clinical trial NCT04612036?
This trial is sponsored by The University of Tennessee, Knoxville, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI